News

Split Biosciences, now Parse Biosciences, Announces $7M in Series A Funding to Democratize Single-Cell RNA Sequencing

As adoption of scRNA-seq in industry and academia accelerates, Parse Biosciences (formerly Split Bio) offers the most flexible and scalable single cell sequencing kit, no custom instrument needed Seattle, WA, January 26, 2021 Split Biosciences, a company providing researchers scalable and flexible single cell sequencing solutions, today announced $7M in Series A funding. The funding […]

Read More

Split Bio Brings Total Financing to Over $2M

Seattle, WA | August 30th, 2019   Split Bio announced the closing of a bridge financing round, bringing the company’s total funding to over $2M. Split Bio will use these funds to scale-up manufacturing of their Whole Transcriptome Single Cell RNA-sequencing kits. These funds will also support ongoing research and development for follow-on applications. Split […]

Read More

Split Biosciences Awarded Small Business Innovation Research (SBIR) Grant from the National Science Foundation

Small Business Innovation Research Program Provides Seed Funding for R&D  Seattle, WA | July 2, 2019 ​Split Biosciences has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to further research and development (R&D) work towards democratizing single-cell RNA sequencing. ​The Seattle-based company is developing a family of kits […]

Read More

Completion of Seed Financing

Seattle, WA | October 12, 2018 Split Biosciences, a Seattle based single-cell analysis company, today announced the recent completion of its seed financing. Split Biosciences is a University of Washington spinout and will use the financing to build upon the groundbreaking single-cell RNA-sequencing technology–SPLiT-seq–published in Science in early 2018. The technology addresses current limitations of single-cell RNA-sequencing […]

Read More